Does IMATINIB Cause Nephrolithiasis? 133 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Nephrolithiasis have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.
133
Reports of Nephrolithiasis with IMATINIB
0.3%
of all IMATINIB reports
6
Deaths
50
Hospitalizations
How Dangerous Is Nephrolithiasis From IMATINIB?
Of the 133 reports, 6 (4.5%) resulted in death, 50 (37.6%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which IMATINIB Alternatives Have Lower Nephrolithiasis Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL